Mark Guerin
Director of Finance/CFO chez TRAWS PHARMA, INC.
Fortune : 36 336 $ au 31/03/2024
Profil
Mark P.
Guerin is currently the Chief Financial Officer at Traws Pharma, Inc. He previously worked as the Director of Financial Reporting & Internal Controls at Barrier Therapeutics, Inc. and as the Chief Financial Officer & Vice President of Finance at CardioKine, Inc. Mr. Guerin obtained his undergraduate degree from DeSales University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TRAWS PHARMA, INC.
0,17% | 14/03/2024 | 35 976 ( 0,17% ) | 36 336 $ | 31/03/2024 |
Postes actifs de Mark Guerin
| Sociétés | Poste | Début |
|---|---|---|
| TRAWS PHARMA, INC. | Director of Finance/CFO | 12/02/2016 |
Anciens postes connus de Mark Guerin
| Sociétés | Poste | Fin |
|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director of Finance/CFO | 01/12/2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - |
Formation de Mark Guerin
| DeSales University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
